Executive Team Expertise Regulus Therapeutics is led by a seasoned executive team with expertise in corporate management, business, science, and drug discovery. This leadership strength can be leveraged to establish strategic partnerships and collaborations.

Recent Promotions The recent promotions within Regulus Therapeutics, such as appointing Rekha Garg as Chief Medical Officer, indicate internal growth and positive momentum in the company. Engaging with the newly promoted executives could lead to potential business opportunities.

Funding and Financial Stability With recent financing of $100 million in equity private placement, Regulus Therapeutics demonstrates financial stability and potential for growth. This indicates a willingness and capability to invest in innovative solutions and partnerships.

Expansion of Leadership Team The expansion of the leadership team with key appointments like Preston S. Klassen as President and Head of Research and Development, showcases Regulus Therapeutics' commitment to strengthening its research capabilities. Engaging with the leadership team can open doors for collaboration and product development opportunities.

Focus on Clinical Development Regulus Therapeutics' focus on clinical development, as evidenced by recent hires like Rekha Garg and Claire Padgett in senior positions, highlights the company's dedication to advancing its pipeline of innovative medicines. Collaborating with the clinical development team can lead to potential partnerships and product advancements.